A new BJS review highlights the potential of 3D organoid models derived from patient cells to help personalise therapy for individuals with gastrointestinal cancers.
Organoids--artificially grown masses of cells or tissues that resemble organs--are being used by researchers in a range of biomedical fields as they study various disease states and work to develop potential treatments.
Organoid culture methods have been established for healthy and diseased tissues from oesophagus, stomach, intestine, pancreas, bile duct, and liver.
Because organoids can be generated with high efficiency and speed from patient samples, they can serve as a personal cancer model that can guide clinical decision-making.
"Research using organoids has already unraveled so many of the underlying causes of cancer. But, for me, their real promise lies in their capacity to predict treatment response," said lead author Merel Aberle, MD, of Maastricht University, in The Netherlands.
"In future, organoids could be used to find the best treatment combination for every patient, thereby increasing response rates, but also reducing the side-effects unnecessary treatment may cause. I hope that this review inspires more surgeons, oncologists, radiologists, and other healthcare professionals to use this model and set up collaborative clinical trials."
Source: WILEY
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.